Thermo Fisher Scientific Inc
NYSE:TMO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
501.29
623.8136
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. stands as a towering entity in the life sciences industry, intricately weaving together science, technology, and business to drive scientific progress and innovation. Founded through a merger of Thermo Electron and Fisher Scientific in 2006, the company has grown exponentially to become a formidable partner for researchers, academicians, and clinicians worldwide. Its business model is built around a broad portfolio of offerings, including laboratory instruments, analytical tools, and consumables, which are crucial for research and quality control. By emphasizing research and development, Thermo Fisher has consistently advanced its technologies, ensuring that its solutions remain indispensable to ventures in pharmaceuticals, biotechnology, and diagnostics.
The strategic acquisition of complementary businesses has been a key facet of Thermo Fisher’s growth, fortifying its position across various scientific fields. In essence, the company thrives on understanding the increasingly complex demands of the scientific community. It generates revenue by capitalizing on its diverse product lineup, subscription-based services, and personalized solutions that cater to specific client needs—ranging from equipment used to perform intricate genomic sequencing to reagents required for advanced laboratory experiments. Thus, Thermo Fisher sustains its financial health through a combination of one-time sales and recurring revenue streams, a strategy that not only reflects its adaptability but also ensures long-term profitability and market leadership in the ever-evolving landscape of scientific research.
Thermo Fisher Scientific Inc. stands as a towering entity in the life sciences industry, intricately weaving together science, technology, and business to drive scientific progress and innovation. Founded through a merger of Thermo Electron and Fisher Scientific in 2006, the company has grown exponentially to become a formidable partner for researchers, academicians, and clinicians worldwide. Its business model is built around a broad portfolio of offerings, including laboratory instruments, analytical tools, and consumables, which are crucial for research and quality control. By emphasizing research and development, Thermo Fisher has consistently advanced its technologies, ensuring that its solutions remain indispensable to ventures in pharmaceuticals, biotechnology, and diagnostics.
The strategic acquisition of complementary businesses has been a key facet of Thermo Fisher’s growth, fortifying its position across various scientific fields. In essence, the company thrives on understanding the increasingly complex demands of the scientific community. It generates revenue by capitalizing on its diverse product lineup, subscription-based services, and personalized solutions that cater to specific client needs—ranging from equipment used to perform intricate genomic sequencing to reagents required for advanced laboratory experiments. Thus, Thermo Fisher sustains its financial health through a combination of one-time sales and recurring revenue streams, a strategy that not only reflects its adaptability but also ensures long-term profitability and market leadership in the ever-evolving landscape of scientific research.
Earnings Calls
Management
Marc N. Casper is the Chairman, President, and Chief Executive Officer of Thermo Fisher Scientific Inc., a leading global provider of scientific instruments, reagents and consumables, and software services. Casper joined the company in 2001 and has held several key leadership positions, including President of the Analytics Technologies business and Chief Operating Officer. Born in 1968, Casper earned his bachelor's degree in economics from Wesleyan University and an MBA from Harvard Business School. His tenure at Thermo Fisher Scientific is marked by significant growth and strategic acquisitions, which have expanded the company's portfolio and global reach. Under his leadership, Thermo Fisher has solidified its reputation as a vital partner in the life sciences sector, supporting pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies. Casper is known for his customer-focused vision, efforts to drive innovation, and commitment to fostering a strong company culture. His work has positioned Thermo Fisher Scientific as a key player in enabling scientific advancements and improving healthcare outcomes worldwide.
Born in 1968, Casper earned his bachelor's degree in economics from Wesleyan University and an MBA from Harvard Business School. His tenure at Thermo Fisher Scientific is marked by significant growth and strategic acquisitions, which have expanded the company's portfolio and global reach. Under his leadership, Thermo Fisher has solidified its reputation as a vital partner in the life sciences sector, supporting pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Casper is known for his customer-focused vision, efforts to drive innovation, and commitment to fostering a strong company culture. His work has positioned Thermo Fisher Scientific as a key player in enabling scientific advancements and improving healthcare outcomes worldwide.
As of the most recent information available, Stephen Williamson is the Executive Vice President, Chief Financial Officer of Thermo Fisher Scientific Inc. He has been serving in this role since August 1, 2015. Prior to his appointment as CFO, Williamson had an extensive career at Thermo Fisher, joining the company in 2001 and holding various financial leadership roles, including Vice President of Financial Operations for several business units. In his role as CFO, Williamson is responsible for leading the company's global finance functions, including financial planning and analysis, accounting, tax, treasury, and investor relations. His leadership has been instrumental in guiding Thermo Fisher’s financial strategy and helping the company achieve its financial and operational goals. Williamson holds a Bachelor of Economics from the University of Warwick and is a Fellow of the Chartered Institute of Management Accountants. Before joining Thermo Fisher, he worked at Honeywell in various finance positions. His expertise in financial management and strategic planning contributes significantly to Thermo Fisher’s status as a leader in the life sciences industry.
In his role as CFO, Williamson is responsible for leading the company's global finance functions, including financial planning and analysis, accounting, tax, treasury, and investor relations. His leadership has been instrumental in guiding Thermo Fisher’s financial strategy and helping the company achieve its financial and operational goals.
Williamson holds a Bachelor of Economics from the University of Warwick and is a Fellow of the Chartered Institute of Management Accountants. Before joining Thermo Fisher, he worked at Honeywell in various finance positions.
His expertise in financial management and strategic planning contributes significantly to Thermo Fisher’s status as a leader in the life sciences industry.
Mr. Michel Lagarde is a prominent executive at Thermo Fisher Scientific Inc., a leading global company in the scientific and healthcare sector. He serves as an Executive Vice President and leads the Pharma Services Group within the company. His expertise and leadership play a significant role in driving the company's mission to enable its customers to make the world healthier, cleaner, and safer. Before his tenure at Thermo Fisher, Lagarde held significant roles in other major companies where he honed his skills in strategic management and operational execution. His vast experience in the industry has been instrumental in expanding Thermo Fisher's capabilities and services, particularly in the pharmaceutical and biotechnological fields.
Lisa P. Britt is an executive at Thermo Fisher Scientific Inc., a global leader in serving science. She serves as the Chief Human Resources Officer and Senior Vice President. In this role, she is responsible for shaping and executing the company’s human resource strategies, which align with its broader strategic objectives. Britt plays a crucial role in fostering a dynamic work environment that drives growth and innovation, ensuring that Thermo Fisher remains an employer of choice for top talent in the science and technology sectors. Under her leadership, the HR department focuses on areas such as talent development, diversity and inclusion, organizational effectiveness, and employee engagement. Britt's work helps support the company’s mission of enabling its customers to make the world healthier, cleaner, and safer. Prior to her current position, she has held various leadership roles in HR across other prominent global organizations, where she consistently drove transformational change and organizational effectiveness. Her extensive experience and strategic mindset make her a key player in Thermo Fisher Scientific's executive team.
Under her leadership, the HR department focuses on areas such as talent development, diversity and inclusion, organizational effectiveness, and employee engagement. Britt's work helps support the company’s mission of enabling its customers to make the world healthier, cleaner, and safer. Prior to her current position, she has held various leadership roles in HR across other prominent global organizations, where she consistently drove transformational change and organizational effectiveness. Her extensive experience and strategic mindset make her a key player in Thermo Fisher Scientific's executive team.
Gianluca Pettiti is a notable executive at Thermo Fisher Scientific Inc., a leading global life sciences company. He currently serves as the Executive Vice President. In his role, Pettiti has been integral in shaping the strategic direction of the company, particularly concerning its financial performance and growth initiatives. Pettiti has a robust background in finance and business strategy, having held various leadership positions within Thermo Fisher. His expertise in the life sciences sector has contributed significantly to the company's expansion and its ability to deliver innovative solutions to its customers. Known for his strategic vision, Pettiti has played a key role in mergers and acquisitions that have strengthened Thermo Fisher's market position. Throughout his career, Gianluca Pettiti has been recognized for his leadership qualities and his ability to drive growth and operational excellence within the organizations he has been part of. His contributions have been pivotal in maintaining Thermo Fisher's edge in a highly competitive industry.
Pettiti has a robust background in finance and business strategy, having held various leadership positions within Thermo Fisher. His expertise in the life sciences sector has contributed significantly to the company's expansion and its ability to deliver innovative solutions to its customers. Known for his strategic vision, Pettiti has played a key role in mergers and acquisitions that have strengthened Thermo Fisher's market position.
Throughout his career, Gianluca Pettiti has been recognized for his leadership qualities and his ability to drive growth and operational excellence within the organizations he has been part of. His contributions have been pivotal in maintaining Thermo Fisher's edge in a highly competitive industry.
Joseph R. Holmes serves as the Senior Vice President and President of Laboratory Products at Thermo Fisher Scientific Inc. In his role, Holmes is responsible for overseeing the development and strategic direction of the company’s laboratory products division, which includes a wide array of products used in scientific research, healthcare, and various industrial applications. With a strong background in leadership and a deep understanding of the life sciences industry, Holmes plays a critical role in driving innovation and operational excellence within the division. His leadership helps ensure that Thermo Fisher Scientific continues to meet the evolving needs of its global customer base, reinforcing the company's position as a leader in the lab products market.
Ryan J. Snyder is the Senior Vice President and Chief Financial Officer (CFO) at Thermo Fisher Scientific Inc., a global leader in serving science. In his role, he is responsible for overseeing the company's financial operations, including financial planning, analysis, and reporting, as well as managing investor relations and business development strategies. Snyder plays a critical part in guiding Thermo Fisher's financial strategies and ensuring its growth and stability in the competitive life sciences industry. His leadership skills and financial expertise contribute significantly to the company's mission of enabling its customers to make the world healthier, cleaner, and safer. Snyder's extensive experience in finance and his strategic insights support Thermo Fisher Scientific in its continued success and innovation.
Dr. Karen E. Nelson is a renowned microbiologist and accomplished executive known for her contributions to the field of microbiology and her leadership in scientific research and development. She currently holds the position of Chief Scientific Officer at Thermo Fisher Scientific Inc., a leading global provider of scientific instrumentation, reagents and consumables, and software services. Dr. Nelson's work has significantly advanced the understanding of the human microbiome and her research focuses on genomics, particularly in microbial ecology and its influence on human health. Before joining Thermo Fisher Scientific, she served as the president of the J. Craig Venter Institute (JCVI), where she led numerous large-scale genomic and metagenomic projects. Under her leadership, several groundbreaking studies were published, contributing to better insights into microbial structures and functions in different environments. Dr. Nelson has authored or co-authored more than 200 peer-reviewed publications, reflecting her influence and thought leadership in the scientific community. Her contributions have been recognized by her election to several prestigious organizations, including the National Academy of Sciences. Dr. Nelson has also been actively involved in various advisory boards and panels, further cementing her role as a pivotal figure in the field of microbiology and genomics. In her role at Thermo Fisher Scientific, Dr. Nelson continues to drive innovation and guide research initiatives that align with the company's mission to enable customers to make the world healthier, cleaner, and safer.
Dr. Nelson's work has significantly advanced the understanding of the human microbiome and her research focuses on genomics, particularly in microbial ecology and its influence on human health. Before joining Thermo Fisher Scientific, she served as the president of the J. Craig Venter Institute (JCVI), where she led numerous large-scale genomic and metagenomic projects.
Under her leadership, several groundbreaking studies were published, contributing to better insights into microbial structures and functions in different environments. Dr. Nelson has authored or co-authored more than 200 peer-reviewed publications, reflecting her influence and thought leadership in the scientific community.
Her contributions have been recognized by her election to several prestigious organizations, including the National Academy of Sciences. Dr. Nelson has also been actively involved in various advisory boards and panels, further cementing her role as a pivotal figure in the field of microbiology and genomics.
In her role at Thermo Fisher Scientific, Dr. Nelson continues to drive innovation and guide research initiatives that align with the company's mission to enable customers to make the world healthier, cleaner, and safer.
Michael A. Boxer served as the Senior Vice President and General Counsel at Thermo Fisher Scientific Inc. In this role, he was responsible for overseeing the company's global legal organization, which includes handling matters related to corporate governance, compliance, intellectual property, and commercial transactions. Before joining Thermo Fisher Scientific, Mr. Boxer held several leadership positions in other notable organizations. He has a rich background in handling complex legal and regulatory issues, often contributing significant strategic counsel to his teams and organizations. His expertise extends across various industries, making him a well-respected figure in the legal and business communities.